APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biologic Therapeutics Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Biologic Therapeutics Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025197 pages

Choose your research edition.

Industry ResearchBiologic Therapeutics Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Biologic Therapeutics Drugs Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Biologic Therapeutics Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biologic Therapeutics Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Biologic Therapeutics Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Biologic Therapeutics Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Biologic Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biologic Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biologic Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biologic Therapeutics Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biologic Therapeutics Drugs include Aurobindo Pharma, Concord Biotech, H. Lundbeck, Retractable Technologies, Smith Medical, AstraZeneca, GlaxoSmithKline, Pfizer and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Biologic Therapeutics Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biologic Therapeutics Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biologic Therapeutics Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Biologic Therapeutics Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Biologic Therapeutics Drugs Segment by Company

Aurobindo Pharma

Concord Biotech

H. Lundbeck

Retractable Technologies

Smith Medical

AstraZeneca

GlaxoSmithKline

Pfizer

Merck

Novartis

Biologic Therapeutics Drugs Segment by Type

Yeast

Insects Cell Culture

Avian Cell Culture

Bacteria

Transgenics

Biologic Therapeutics Drugs Segment by Application

Diabetes

Anemia

Rheumatoid Arthritis

Cancer

Others

Biologic Therapeutics Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic Therapeutics Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biologic Therapeutics Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic Therapeutics Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biologic Therapeutics Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biologic Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Biologic Therapeutics Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Biologic Therapeutics Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Biologic Therapeutics Drugs Industry Trends Table 2. Biologic Therapeutics Drugs Industry Drivers Table 3. Biologic Therapeutics Drugs Industry Opportunities and Challenges Table 4. Biologic Therapeutics Drugs Industry Restraints Table 5. Global Biologic Therapeutics Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Biologic Therapeutics Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Biologic Therapeutics Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Biologic Therapeutics Drugs Sales Market Share by Manufacturers Table 9. Global Biologic Therapeutics Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Biologic Therapeutics Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Biologic Therapeutics Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Biologic Therapeutics Drugs Manufacturers, Product Type & Application Table 13. Global Biologic Therapeutics Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Biologic Therapeutics Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Yeast Table 17. Major Manufacturers of Insects Cell Culture Table 18. Major Manufacturers of Avian Cell Culture Table 19. Major Manufacturers of Bacteria Table 20. Major Manufacturers of Transgenics Table 21. Global Biologic Therapeutics Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Biologic Therapeutics Drugs Sales by Type (2021-2026) & (K Units) Table 23. Global Biologic Therapeutics Drugs Sales by Type (2027-2032) & (K Units) Table 24. Global Biologic Therapeutics Drugs Sales Market Share by Type (2021-2026) Table 25. Global Biologic Therapeutics Drugs Sales Market Share by Type (2027-2032) Table 26. Global Biologic Therapeutics Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Biologic Therapeutics Drugs Revenue by Type (2021-2026) & (K Units) Table 28. Global Biologic Therapeutics Drugs Revenue by Type (2027-2032) & (K Units) Table 29. Global Biologic Therapeutics Drugs Revenue Market Share by Type (2021-2026) Table 30. Global Biologic Therapeutics Drugs Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Diabetes Table 32. Major Manufacturers of Anemia Table 33. Major Manufacturers of Rheumatoid Arthritis Table 34. Major Manufacturers of Cancer Table 35. Major Manufacturers of Others Table 36. Global Biologic Therapeutics Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Biologic Therapeutics Drugs Sales by Application (2021-2026) & (K Units) Table 38. Global Biologic Therapeutics Drugs Sales by Application (2027-2032) & (K Units) Table 39. Global Biologic Therapeutics Drugs Sales Market Share by Application (2021-2026) Table 40. Global Biologic Therapeutics Drugs Sales Market Share by Application (2027-2032) Table 41. Global Biologic Therapeutics Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Biologic Therapeutics Drugs Revenue by Application (2021-2026) & (K Units) Table 43. Global Biologic Therapeutics Drugs Revenue by Application (2027-2032) & (K Units) Table 44. Global Biologic Therapeutics Drugs Revenue Market Share by Application (2021-2026) Table 45. Global Biologic Therapeutics Drugs Revenue Market Share by Application (2027-2032) Table 46. Global Biologic Therapeutics Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Biologic Therapeutics Drugs Sales by Region (2021-2026) & (K Units) Table 48. Global Biologic Therapeutics Drugs Sales Market Share by Region (2021-2026) Table 49. Global Biologic Therapeutics Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Biologic Therapeutics Drugs Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Biologic Therapeutics Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Biologic Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 53. North America Biologic Therapeutics Drugs Sales by Country (2027-2032) & (K Units) Table 54. Europe Biologic Therapeutics Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Biologic Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 56. Europe Biologic Therapeutics Drugs Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Biologic Therapeutics Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Biologic Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Biologic Therapeutics Drugs Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Biologic Therapeutics Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Biologic Therapeutics Drugs Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Biologic Therapeutics Drugs Sales by Country (2027-2032) & (K Units) Table 63. Global Biologic Therapeutics Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Biologic Therapeutics Drugs Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Biologic Therapeutics Drugs Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Biologic Therapeutics Drugs Revenue Market Share by Region (2021-2026) Table 67. Global Biologic Therapeutics Drugs Revenue Market Share by Region (2027-2032) Table 68. Aurobindo Pharma Company Information Table 69. Aurobindo Pharma Business Overview Table 70. Aurobindo Pharma Biologic Therapeutics Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Aurobindo Pharma Biologic Therapeutics Drugs Product Portfolio Table 72. Aurobindo Pharma Recent Development Table 73. Concord Biotech Company Information Table 74. Concord Biotech Business Overview Table 75. Concord Biotech Biologic Therapeutics Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Concord Biotech Biologic Therapeutics Drugs Product Portfolio Table 77. Concord Biotech Recent Development Table 78. H. Lundbeck Company Information Table 79. H. Lundbeck Business Overview Table 80. H. Lundbeck Biologic Therapeutics Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. H. Lundbeck Biologic Therapeutics Drugs Product Portfolio Table 82. H. Lundbeck Recent Development Table 83. Retractable Technologies Company Information Table 84. Retractable Technologies Business Overview Table 85. Retractable Technologies Biologic Therapeutics Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Retractable Technologies Biologic Therapeutics Drugs Product Portfolio Table 87. Retractable Technologies Recent Development Table 88. Smith Medical Company Information Table 89. Smith Medical Business Overview Table 90. Smith Medical Biologic Therapeutics Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Smith Medical Biologic Therapeutics Drugs Product Portfolio Table 92. Smith Medical Recent Development Table 93. AstraZeneca Company Information Table 94. AstraZeneca Business Overview Table 95. AstraZeneca Biologic Therapeutics Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. AstraZeneca Biologic Therapeutics Drugs Product Portfolio Table 97. AstraZeneca Recent Development Table 98. GlaxoSmithKline Company Information Table 99. GlaxoSmithKline Business Overview Table 100. GlaxoSmithKline Biologic Therapeutics Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. GlaxoSmithKline Biologic Therapeutics Drugs Product Portfolio Table 102. GlaxoSmithKline Recent Development Table 103. Pfizer Company Information Table 104. Pfizer Business Overview Table 105. Pfizer Biologic Therapeutics Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Pfizer Biologic Therapeutics Drugs Product Portfolio Table 107. Pfizer Recent Development Table 108. Merck Company Information Table 109. Merck Business Overview Table 110. Merck Biologic Therapeutics Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Merck Biologic Therapeutics Drugs Product Portfolio Table 112. Merck Recent Development Table 113. Novartis Company Information Table 114. Novartis Business Overview Table 115. Novartis Biologic Therapeutics Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Novartis Biologic Therapeutics Drugs Product Portfolio Table 117. Novartis Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Biologic Therapeutics Drugs Distributors List Table 121. Biologic Therapeutics Drugs Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Biologic Therapeutics Drugs Product Image Figure 2. Global Biologic Therapeutics Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biologic Therapeutics Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Biologic Therapeutics Drugs Sales (2021-2032) & (K Units) Figure 5. Global Biologic Therapeutics Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Biologic Therapeutics Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Yeast Image Figure 9. Insects Cell Culture Image Figure 10. Avian Cell Culture Image Figure 11. Bacteria Image Figure 12. Transgenics Image Figure 13. Global Biologic Therapeutics Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Biologic Therapeutics Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Biologic Therapeutics Drugs Sales Market Share by Type (2021-2032) Figure 16. Global Biologic Therapeutics Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Biologic Therapeutics Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Biologic Therapeutics Drugs Revenue Market Share by Type (2021-2032) Figure 19. Diabetes Image Figure 20. Anemia Image Figure 21. Rheumatoid Arthritis Image Figure 22. Cancer Image Figure 23. Others Image Figure 24. Global Biologic Therapeutics Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Biologic Therapeutics Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Biologic Therapeutics Drugs Sales Market Share by Application (2021-2032) Figure 27. Global Biologic Therapeutics Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Biologic Therapeutics Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Biologic Therapeutics Drugs Revenue Market Share by Application (2021-2032) Figure 30. North America Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Biologic Therapeutics Drugs Sales Market Share by Country (2021-2032) Figure 32. U.S. Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Biologic Therapeutics Drugs Sales Market Share by Country (2021-2032) Figure 37. Germany Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Biologic Therapeutics Drugs Sales Market Share by Country (2021-2032) Figure 44. China Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Biologic Therapeutics Drugs Sales Market Share by Country (2021-2032) Figure 52. Brazil Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Biologic Therapeutics Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Biologic Therapeutics Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Biologic Therapeutics Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Figure 63. North America Biologic Therapeutics Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Figure 65. Europe Biologic Therapeutics Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Biologic Therapeutics Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Biologic Therapeutics Drugs Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Biologic Therapeutics Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Biologic Therapeutics Drugs Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Biologic Therapeutics Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Yeast
  • Insects Cell Culture
  • Avian Cell Culture
  • Bacteria
  • Transgenics
Applications
  • Diabetes
  • Anemia
  • Rheumatoid Arthritis
  • Cancer
  • Others
Companies covered
  • Aurobindo Pharma
  • Concord Biotech
  • H. Lundbeck
  • Retractable Technologies
  • Smith Medical
  • AstraZeneca
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biologic Therapeutics Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biologic Therapeutics Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Biologic Therapeutics Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Biologic Therapeutics Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Biologic Therapeutics Drugs Market Dynamics
  1. 2.1 Biologic Therapeutics Drugs Industry Trends
  2. 2.2 Biologic Therapeutics Drugs Industry Drivers
  3. 2.3 Biologic Therapeutics Drugs Industry Opportunities and Challenges
  4. 2.4 Biologic Therapeutics Drugs Industry Restraints
3 Biologic Therapeutics Drugs Market by Manufacturers
  1. 3.1 Global Biologic Therapeutics Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Biologic Therapeutics Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Biologic Therapeutics Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Biologic Therapeutics Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Biologic Therapeutics Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Biologic Therapeutics Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Biologic Therapeutics Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Biologic Therapeutics Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Biologic Therapeutics Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Biologic Therapeutics Drugs Tier 1, Tier 2, and Tier 3
4 Biologic Therapeutics Drugs Market by Type
  1. 4.1 Biologic Therapeutics Drugs Type Introduction
  2. 4.1.1 Yeast
  3. 4.1.2 Insects Cell Culture
  4. 4.1.3 Avian Cell Culture
  5. 4.1.4 Bacteria
  6. 4.1.5 Transgenics
  7. 4.2 Global Biologic Therapeutics Drugs Sales by Type
  8. 4.2.1 Global Biologic Therapeutics Drugs Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Biologic Therapeutics Drugs Sales by Type (2021-2032)
  10. 4.2.3 Global Biologic Therapeutics Drugs Sales Market Share by Type (2021-2032)
  11. 4.3 Global Biologic Therapeutics Drugs Revenue by Type
  12. 4.3.1 Global Biologic Therapeutics Drugs Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Biologic Therapeutics Drugs Revenue by Type (2021-2032)
  14. 4.3.3 Global Biologic Therapeutics Drugs Revenue Market Share by Type (2021-2032)
5 Biologic Therapeutics Drugs Market by Application
  1. 5.1 Biologic Therapeutics Drugs Application Introduction
  2. 5.1.1 Diabetes
  3. 5.1.2 Anemia
  4. 5.1.3 Rheumatoid Arthritis
  5. 5.1.4 Cancer
  6. 5.1.5 Others
  7. 5.2 Global Biologic Therapeutics Drugs Sales by Application
  8. 5.2.1 Global Biologic Therapeutics Drugs Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Biologic Therapeutics Drugs Sales by Application (2021-2032)
  10. 5.2.3 Global Biologic Therapeutics Drugs Sales Market Share by Application (2021-2032)
  11. 5.3 Global Biologic Therapeutics Drugs Revenue by Application
  12. 5.3.1 Global Biologic Therapeutics Drugs Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Biologic Therapeutics Drugs Revenue by Application (2021-2032)
  14. 5.3.3 Global Biologic Therapeutics Drugs Revenue Market Share by Application (2021-2032)
6 Global Biologic Therapeutics Drugs Sales by Region
  1. 6.1 Global Biologic Therapeutics Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biologic Therapeutics Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Biologic Therapeutics Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Biologic Therapeutics Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biologic Therapeutics Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Biologic Therapeutics Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Biologic Therapeutics Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Biologic Therapeutics Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Biologic Therapeutics Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Biologic Therapeutics Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Biologic Therapeutics Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Biologic Therapeutics Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Biologic Therapeutics Drugs Revenue by Region
  1. 7.1 Global Biologic Therapeutics Drugs Revenue by Region
  2. 7.1.1 Global Biologic Therapeutics Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Biologic Therapeutics Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Biologic Therapeutics Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Biologic Therapeutics Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Biologic Therapeutics Drugs Revenue (2021-2032)
  8. 7.2.2 North America Biologic Therapeutics Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Biologic Therapeutics Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Biologic Therapeutics Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Biologic Therapeutics Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Biologic Therapeutics Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Biologic Therapeutics Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Biologic Therapeutics Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Aurobindo Pharma
  2. 8.1.1 Aurobindo Pharma Company Information
  3. 8.1.2 Aurobindo Pharma Business Overview
  4. 8.1.3 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aurobindo Pharma Biologic Therapeutics Drugs Product Portfolio
  6. 8.1.5 Aurobindo Pharma Recent Developments
  7. 8.2 Concord Biotech
  8. 8.2.1 Concord Biotech Company Information
  9. 8.2.2 Concord Biotech Business Overview
  10. 8.2.3 Concord Biotech Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Concord Biotech Biologic Therapeutics Drugs Product Portfolio
  12. 8.2.5 Concord Biotech Recent Developments
  13. 8.3 H. Lundbeck
  14. 8.3.1 H. Lundbeck Company Information
  15. 8.3.2 H. Lundbeck Business Overview
  16. 8.3.3 H. Lundbeck Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 H. Lundbeck Biologic Therapeutics Drugs Product Portfolio
  18. 8.3.5 H. Lundbeck Recent Developments
  19. 8.4 Retractable Technologies
  20. 8.4.1 Retractable Technologies Company Information
  21. 8.4.2 Retractable Technologies Business Overview
  22. 8.4.3 Retractable Technologies Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Retractable Technologies Biologic Therapeutics Drugs Product Portfolio
  24. 8.4.5 Retractable Technologies Recent Developments
  25. 8.5 Smith Medical
  26. 8.5.1 Smith Medical Company Information
  27. 8.5.2 Smith Medical Business Overview
  28. 8.5.3 Smith Medical Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Smith Medical Biologic Therapeutics Drugs Product Portfolio
  30. 8.5.5 Smith Medical Recent Developments
  31. 8.6 AstraZeneca
  32. 8.6.1 AstraZeneca Company Information
  33. 8.6.2 AstraZeneca Business Overview
  34. 8.6.3 AstraZeneca Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AstraZeneca Biologic Therapeutics Drugs Product Portfolio
  36. 8.6.5 AstraZeneca Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Biologic Therapeutics Drugs Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Biologic Therapeutics Drugs Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merck Biologic Therapeutics Drugs Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 Novartis
  56. 8.10.1 Novartis Company Information
  57. 8.10.2 Novartis Business Overview
  58. 8.10.3 Novartis Biologic Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novartis Biologic Therapeutics Drugs Product Portfolio
  60. 8.10.5 Novartis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Biologic Therapeutics Drugs Value Chain Analysis
  2. 9.1.1 Biologic Therapeutics Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Biologic Therapeutics Drugs Production Mode & Process
  6. 9.2 Biologic Therapeutics Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Biologic Therapeutics Drugs Distributors
  9. 9.2.3 Biologic Therapeutics Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst